Results 91 to 100 of about 21,493 (233)
European Eating Disorders Review, Volume 34, Issue 4, Page 895-906, July 2026.ABSTRACT Objective Outpatient treatment for bulimia nervosa (BN) often fails to reduce core symptoms like binge eating and purging, while inpatient care is costly and separates patients from their everyday environment. Day‐patient treatment offers a middle ground by providing intensive daytime therapy with the opportunity to apply skills at home.
Anna L. Dieffenbacher +2 more
wiley +1 more source
European Eating Disorders Review, Volume 34, Issue 4, Page 926-945, July 2026.ABSTRACT Objective Anorexia nervosa (AN) is a severe psychiatric disorder displaying an altered gut microbiome. Faecal microbiome transplantation (FMT) has emerged as a powerful research tool and potential treatment option in AN due to the microbiome‐gut‐brain axis. Current studies are limited and reveal variable FMT protocols.
Anna C. Thelen +6 more
wiley +1 more source
A Systematic Scoping Review of Factors Contributing to Loss of Control Eating During Pregnancy
European Eating Disorders Review, Volume 34, Issue 4, Page 1022-1047, July 2026.ABSTRACT Objective Evidence suggests loss of control eating (LOC) during pregnancy is prevalent and linked to adverse health consequences for birthing individuals and their offspring; however, factors underlying risk for prenatal LOC remain unclear.
Riley J. Jouppi +3 more
wiley +1 more source
European Eating Disorders Review, Volume 34, Issue 4, Page 1089-1098, July 2026.ABSTRACT Objective Gaining access to evidence‐informed treatment for eating disorders (EDs) is challenging, and this creates interest in the possible benefits of self‐help treatment methods. We investigated the effectiveness of receiving evidence‐informed self‐guided psychoeducation, delivered to individuals while on a waitlist for specialised ED care.
Linda Booij +5 more
wiley +1 more source
European Eating Disorders Review, Volume 34, Issue 4, Page 1058-1064, July 2026.ABSTRACT Objective The early response effect, defined as a reliable symptomatic improvement during the initial phase of treatment, is the most robust predictor of recovery following eating disorder treatment. This study aimed to investigate which symptom domains mostly influence the early response effect. Methods Data from N = 232 adult patients (90.8%
Ammara Imtiaz +3 more
wiley +1 more source
European Eating Disorders Review, Volume 34, Issue 4, Page 1075-1088, July 2026.ABSTRACT Objective We examined the clinical validity of DSM‐5 severity specifiers for bulimia nervosa (BN) and binge eating disorder (BED) in Korean outpatients. Method Seven hundred ninety‐nine outpatients with BN (n = 668; mean age = 23.7 years; 95% female; mean BMI = 20.54 kg/m2) or BED (n = 131; mean age = 26.1 years; 89% female; mean BMI = 25.07 ...
Zhen An, Youl‐Ri Kim, Janet Treasure
wiley +1 more source
European Eating Disorders Review, Volume 34, Issue 4, Page 1121-1129, July 2026.ABSTRACT Objective Compulsive exercise is a common behaviour among persons with eating disorders, particularly in those with anorexia nervosa (AN) and bulimia nervosa (BN). In the current study, we examined psychometric properties of a German version of the eight‐item Commitment to Exercise Scale (CES) with a four‐point scale response format.
Fiona M. Fabry +5 more
wiley +1 more source
A method for the preparation of the colon for examination and surgery
Амбулаторная хирургия, 2016 The past three decades have seen a steady increase in the incidence of colon cancer. Malignant obstruction of the colon is the second most common obstruction after adhesion.
M. D. Dibirov
doaj
Journal of Clinical Psychology, Volume 82, Issue 7, Page 1078-1085, July 2026.ABSTRACT Objective Gastrointestinal (GI) disturbances and eating disorder symptoms commonly co‐occur. Hypervigilance and anxiety about GI symptoms may motivate eating disorder behaviors to manage and/or avoid GI symptoms. We hypothesized that GI‐specific anxiety would be more strongly associated with dietary restriction and purging than GI‐specific ...
Gabriella Pucci +6 more
wiley +1 more source
Diabetes, Obesity and Metabolism, Volume 28, Issue 7, Page 5952-5967, July 2026.ABSTRACT Aims To evaluate the effects of probiotics Bifidobacterium bifidum G9‐1 (BBG9‐1) on gastrointestinal symptoms in patients with Type 2 diabetes mellitus (T2DM) with diarrhoea or constipation. Materials and Methods In a 12‐week open‐label randomised controlled trial, 100 participants were randomized 1:1 to a control or BBG9‐1 group, with 12 mg ...
Genki Kobayashi +10 more
wiley +1 more source